OPKO Health
OPK
₹117.56
Share price
0.00%
Change (1 day)
-1.83%
Change (1 year)
Categories
OPKO Health (OPK) - Total assets
Total assets on the balance sheet as of March 2025 : ₹185.33 Billion
According to OPKO Health 's latest financial reports the company's total assets are ₹185.33 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
OPKO Health - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | ₹188.74 B | 12.7% |
| 2023-12-31 | ₹167.47 B | -6.62% |
| 2022-12-31 | ₹179.34 B | 0.41% |
| 2021-12-31 | ₹178.61 B | -1.24% |
| 2020-12-31 | ₹180.86 B | 9.83% |
| 2019-12-31 | ₹164.67 B | -3.91% |
| 2018-12-31 | ₹171.38 B | 3.64% |
| 2017-12-31 | ₹165.37 B | -12.04% |
| 2016-12-31 | ₹188.00 B | 1.07% |
| 2015-12-31 | ₹186.02 B | 131.54% |
| 2014-12-31 | ₹80.34 B | -6.54% |
| 2013-12-31 | ₹85.96 B | 441.73% |
| 2012-12-31 | ₹15.86 B | 30.72% |
| 2011-12-31 | ₹12.13 B | 248.02% |
| 2010-12-31 | ₹3.48 B | -14.01% |
| 2009-12-31 | ₹4.05 B | 287.8% |
| 2008-12-31 | ₹1.04 B | -32.63% |
| 2007-12-31 | ₹1.55 B | 30124.89% |
| 2006-12-31 | ₹5.13 M | -98.73% |
| 2005-12-31 | ₹0.40 B | -7.14% |
| 2004-12-31 | ₹0.43 B | -15.54% |
| 2003-12-31 | ₹0.51 B | -38.52% |
| 2002-12-31 | ₹0.83 B | -36.99% |
| 2001-12-31 | ₹1.33 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | ₹16.864 T | 8,999.67% | 🇺🇸 USA |
 Abbott Laboratories ABT | ₹7.092 T | 3,726.85% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | ₹3.269 T | 1,664.07% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | ₹3.345 T | 1,704.94% | 🇮🇱 Israel |
 Alnylam Pharmaceuticals
ALNY | ₹366.93 B | 97.99% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | ₹8.048 T | 4,242.70% | 🇺🇸 USA |
 LabCorp LH | ₹1.532 T | 727.12% | 🇺🇸 USA |
 Ardelyx ARDX | ₹35.71 B | -80.73% | 🇺🇸 USA |